help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wier, M. L.
Right arrow Articles by Scott, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wier, M. L.
Right arrow Articles by Scott, R. E.

American Journal of Pathology, Vol 125, 546-554, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation [published erratum appears in Am J Pathol 1988 Mar;130(3):642]

ML Wier and RE Scott

Cellular proliferation is regulated not only by the action of growth factors and growth inhibitors whose effects are reversible but also by factors that induce the irreversible loss of proliferative potential associated with the terminal event in cellular differentiation. The authors have employed 3T3 T mesenchymal stem cells as a model system to study the terminal event in cellular differentiation because in these cells' distinct nonterminal and terminal states of differentiation can be identified and because transition from the nonterminal to the terminal states of differentiation can be induced by human plasma. In this paper is reported the 20,000-fold purification of a component of human plasma that induces the terminal event in differentiation. This factor is shown to have an apparent molecular weight of approximately 45,000 and an isoelectric point of approximately 7.6. It is trypsin- sensitive, acid and heat-labile, and is resistant to treatment with dithiothreitol and alkali. The ability of this human plasma protein to induce the irreversible loss of proliferative potential associated with the terminal event in differentiation serves as the basis for its designation "aproliferin." The data in this paper in addition show that no other pharmacologic or physiologic agents have been identified that can mimic the biologic effect of aproliferin. Therefore, aproliferin appears to be a functionally distinct protein in human plasma.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. M. Witte and R. E. Scott
The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation
PNAS, February 18, 1997; 94(4): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Smyth, R. Sparks, and W Wharton
Proadipocyte cell lines: models of cellular proliferation and differentiation
J. Cell Sci., January 9, 1993; 106(1): 1 - 9.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.